US 9309231
Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof
granted A61KA61K31/4178A61K31/4184
Quick answer
US patent 9309231 (Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/4178, A61K31/4184, A61K31/427, A61K31/439